1-17048193-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_003000.3(SDHB):c.73-3305G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.421 in 152,108 control chromosomes in the GnomAD database, including 15,129 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.42   (  15129   hom.,  cov: 33) 
Consequence
 SDHB
NM_003000.3 intron
NM_003000.3 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.167  
Publications
7 publications found 
Genes affected
 SDHB  (HGNC:10681):  (succinate dehydrogenase complex iron sulfur subunit B) This tumor suppressor gene encodes the iron-sulfur protein subunit of the succinate dehydrogenase (SDH) enzyme complex which plays a critical role in mitochondria. The SDH enzyme complex is composed of four nuclear-encoded subunits. This enzyme complex converts succinate to fumarate which releases electrons as part of the citric acid cycle, and the enzyme complex additionally provides an attachment site for released electrons to be transferred to the oxidative phosphorylation pathway. The SDH enzyme complex plays a role in oxygen-related gene regulation through its conversion of succinate, which is an oxygen sensor that stabilizes the hypoxia-inducible factor 1 (HIF1) transcription factor. Sporadic and familial mutations in this gene result in paragangliomas, pheochromocytoma, and gastrointestinal stromal tumors, supporting a link between mitochondrial dysfunction and tumorigenesis. Mutations in this gene are also implicated in nuclear type 4 mitochondrial complex II deficiency. [provided by RefSeq, Jun 2022] 
SDHB Gene-Disease associations (from GenCC):
- Carney-Stratakis syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
 - gastrointestinal stromal tumorInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
 - hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
 - pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
 - pheochromocytoma/paraganglioma syndrome 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
 - mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
 - renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - mitochondrial complex 2 deficiency, nuclear type 4Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - Cowden diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - mitochondrial complex II deficiencyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.537  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.421  AC: 64024AN: 151990Hom.:  15127  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
64024
AN: 
151990
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.421  AC: 64028AN: 152108Hom.:  15129  Cov.: 33 AF XY:  0.418  AC XY: 31098AN XY: 74370 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
64028
AN: 
152108
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
31098
AN XY: 
74370
show subpopulations 
African (AFR) 
 AF: 
AC: 
8191
AN: 
41500
American (AMR) 
 AF: 
AC: 
6969
AN: 
15270
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1582
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
1552
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
2168
AN: 
4830
European-Finnish (FIN) 
 AF: 
AC: 
5184
AN: 
10562
Middle Eastern (MID) 
 AF: 
AC: 
141
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
36786
AN: 
67978
Other (OTH) 
 AF: 
AC: 
924
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 1770 
 3540 
 5309 
 7079 
 8849 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 600 
 1200 
 1800 
 2400 
 3000 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1234
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.